CSTL
Castle Biosciences Inc
NASDAQ: CSTL · HEALTHCARE · DIAGNOSTICS & RESEARCH
$24.24
-1.82% today
Updated 2026-04-29
Market cap
$734.37M
P/E ratio
—
P/S ratio
2.13x
EPS (TTM)
$-0.83
Dividend yield
—
52W range
$15 – $44
Volume
0.4M
Castle Biosciences Inc (CSTL) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$24.24
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$96.60
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.2B | $0.3B | $0.3B | $0.4B | $0.5B | $0.6B | $0.7B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -7.02%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.